Scholarlink

Objective <p>To evaluate the success and complications of thermal ablation (TA) based on the voluntary, prospective registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) with 303 participating centers from Germany, Austria, and Switzerland.</p> Materials and methods <p>Registry data from 2018 until 2023 of 1102 patients with small renal tumors (age: 72.5 ± 11.6 years; female: 33.6%, 370/1102) were analyzed. Hospitals with ≥ 20 TAs were considered high-volume centers. Technical success and complication rates between different parameters were compared using the chi-square or Fisher’s exact test, <i>p</i> &lt; 0.05 was considered statistically significant.</p> Results <p>Patients were most frequently treated with radiofrequency ablation (RFA, 43.6%, 481/1102), then microwave ablation (MWA, 41.9%, 462/1102) or cryoablation (13.3%, 147/1102). Technical success for heat-based TA (RFA&amp;MWA) was 94.3% (893/947), for cryoablation 97.3% (143/147). RFA&amp;MWA was significantly more successful in lesions ≤ 3 cm (96.1%, 567/590) compared to 3–4 cm lesions (89.8%, 97/108; <i>p</i> = 0.005). In patients treated with cryoablation, no significant differences between sizes could be found (≤ 3 cm: 97.9%, 94/96; 3–4 cm: 85.7%, 12/14; <i>p</i> = 0.078). Complication rate was significantly higher in RFA&amp;MWA of lesions 3–4 cm compared to ≤ 3 cm (≤ 3 cm: 3.9%, 23/590; 3–4 cm: 11.1%, 12/108, <i>p</i> = 0.002), while no significant differences were seen regarding cryoablation (≤ 3 cm: 1.0%, 1/96; 3–4 cm: 0.0%, 0/14; <i>p</i> = 1.000).</p> Conclusions <p>In this exploratory analysis of the DeGIR registry, percutaneous TA of small renal masses is technically feasible with low complication rates. Heat-based TAs seem to have lower success rates and higher complication rates in larger tumors. Cryoablation could potentially be a safe alternative for 3- to 4-cm-sized tumors.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>How effective is renal thermal ablation (TA) in terms of treatment success and complication rates?</i></p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>In contrast to cryoablation, heat-based thermal ablation has lower success and higher complication rates in tumors measuring 3–4 cm compared to tumors &lt; 3 cm</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>Thermal ablation is not influenced by the need for additional techniques such as cooling, protective organ displacement, or temporary vessel occlusion. For small renal tumors, TA is an effective and safe treatment option. Cryoablation could be beneficial in larger tumors.</i></p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年2月28日

查看全文
  • Benedikt M. Schaarschmidt,
  • Sebastian Zensen,
  • Claudia Kesch,
  • Thomas Dertnig,
  • Marcel Opitz,
  • Marcel Drews,
  • Jonathan Nadjiri,
  • Michael Forsting,
  • Boris A. Hadaschik,
  • Johannes Haubold

摘要

Objective

To evaluate the success and complications of thermal ablation (TA) based on the voluntary, prospective registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) with 303 participating centers from Germany, Austria, and Switzerland.

Materials and methods

Registry data from 2018 until 2023 of 1102 patients with small renal tumors (age: 72.5 ± 11.6 years; female: 33.6%, 370/1102) were analyzed. Hospitals with ≥ 20 TAs were considered high-volume centers. Technical success and complication rates between different parameters were compared using the chi-square or Fisher’s exact test, p < 0.05 was considered statistically significant.

Results

Patients were most frequently treated with radiofrequency ablation (RFA, 43.6%, 481/1102), then microwave ablation (MWA, 41.9%, 462/1102) or cryoablation (13.3%, 147/1102). Technical success for heat-based TA (RFA&MWA) was 94.3% (893/947), for cryoablation 97.3% (143/147). RFA&MWA was significantly more successful in lesions ≤ 3 cm (96.1%, 567/590) compared to 3–4 cm lesions (89.8%, 97/108; p = 0.005). In patients treated with cryoablation, no significant differences between sizes could be found (≤ 3 cm: 97.9%, 94/96; 3–4 cm: 85.7%, 12/14; p = 0.078). Complication rate was significantly higher in RFA&MWA of lesions 3–4 cm compared to ≤ 3 cm (≤ 3 cm: 3.9%, 23/590; 3–4 cm: 11.1%, 12/108, p = 0.002), while no significant differences were seen regarding cryoablation (≤ 3 cm: 1.0%, 1/96; 3–4 cm: 0.0%, 0/14; p = 1.000).

Conclusions

In this exploratory analysis of the DeGIR registry, percutaneous TA of small renal masses is technically feasible with low complication rates. Heat-based TAs seem to have lower success rates and higher complication rates in larger tumors. Cryoablation could potentially be a safe alternative for 3- to 4-cm-sized tumors.

Key Points

Question How effective is renal thermal ablation (TA) in terms of treatment success and complication rates?

Findings In contrast to cryoablation, heat-based thermal ablation has lower success and higher complication rates in tumors measuring 3–4 cm compared to tumors < 3 cm.

Clinical relevance Thermal ablation is not influenced by the need for additional techniques such as cooling, protective organ displacement, or temporary vessel occlusion. For small renal tumors, TA is an effective and safe treatment option. Cryoablation could be beneficial in larger tumors.

Graphical Abstract